Perfluoroalkyl substances are increased in patients with late-onset ulcerative colitis and induce intestinal barrier defects ex vivo in murine intestinal tissue
暂无分享,去创建一个
M. Orešič | T. Hyötyläinen | I. Schoultz | J. Halfvarson | M. Gareau | S. Salihović | T. Hyotylainen | A. McGlinchey | F. Fart | Aidan J. McGlinchey
[1] Å. Keita,et al. Colonic paracellular permeability and circulating zonulin-related proteins , 2021, Scandinavian journal of gastroenterology.
[2] J. Irudayaraj,et al. Effect of Perfluorooctanoic Acid on the Epigenetic and Tight Junction Genes of the Mouse Intestine , 2020, Toxics.
[3] Å. Keita,et al. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability , 2020, Cells.
[4] A. Braeuning,et al. Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells , 2020, Archives of Toxicology.
[5] M. Dubinsky,et al. Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth. , 2020, Gastroenterology.
[6] H. Sokol,et al. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.
[7] David S. Wishart,et al. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis , 2019, Current protocols in bioinformatics.
[8] D. Philpott,et al. Nod‐like receptors are critical for gut–brain axis signalling in mice , 2019, The Journal of physiology.
[9] M. Orešič,et al. Simultaneous determination of perfluoroalkyl substances and bile acids in human serum using ultra-high-performance liquid chromatography–tandem mass spectrometry , 2019, Analytical and Bioanalytical Chemistry.
[10] T. Fletcher,et al. Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. , 2019, Environmental research.
[11] P. Munkholm,et al. Dietary risk factors for inflammatory bowel diseases in a high-risk population: Results from the Faroese IBD study , 2019, United European gastroenterology journal.
[12] M. DeVito,et al. Toxicokinetics of 8:2 fluorotelomer alcohol (8:2-FTOH) in male and female Hsd:Sprague Dawley SD rats after intravenous and gavage administration , 2019, Toxicology reports.
[13] Å. Keita,et al. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function , 2019, Cells.
[14] David L. Smith,et al. Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms , 2019, PloS one.
[15] P. Gibson,et al. Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems , 2019, PloS one.
[16] D. Greco,et al. Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci , 2018, Inflammatory bowel diseases.
[17] J. Allen,et al. A Review of the Pathways of Human Exposure to Poly- and Perfluoroalkyl Substances (PFASs) and Present Understanding of Health Effects , 2018, Journal of Exposure Science & Environmental Epidemiology.
[18] S. Kugathasan,et al. PFOA and ulcerative colitis , 2018, Environmental research.
[19] W. Alrefai,et al. Pathophysiology of IBD associated diarrhea , 2018, Tissue barriers.
[20] Jonas Halfvarson,et al. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. , 2017, Gastroenterology.
[21] J. Chiang. Recent advances in understanding bile acid homeostasis , 2017, F1000Research.
[22] George Michailidis,et al. Sparse network modeling and metscape‐based visualization methods for the analysis of large‐scale metabolomics data , 2017, Bioinform..
[23] Lisa M Bramer,et al. Dynamics of the human gut microbiome in Inflammatory Bowel Disease , 2017, Nature Microbiology.
[24] J. Forster,et al. Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[25] R. Baldassano,et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases. , 2015, Gastroenterology.
[26] Ashwin N. Ananthakrishnan,et al. Epidemiology and risk factors for IBD , 2015, Nature Reviews Gastroenterology &Hepatology.
[27] M. D’Amato,et al. Polymorphism in the Retinoic Acid Metabolizing Enzyme CYP26B1 and the Development of Crohn’s Disease , 2013, PloS one.
[28] K. Steenland,et al. Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in a Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley , 2013, Environmental health perspectives.
[29] A. Tjønneland,et al. Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish Population , 2013, PloS one.
[30] P. Suñé,et al. Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results , 2013, PloS one.
[31] H. Sokol,et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases , 2012, Gut.
[32] A. Lampen,et al. Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4α). , 2012, Toxicology letters.
[33] J. M. Keller,et al. Immunotoxicity of Perfluorinated Compounds: Recent Developments , 2012, Toxicologic pathology.
[34] Y. Schneider,et al. Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model. , 2011, Toxicology letters.
[35] M. V. van Erk,et al. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[36] M. Lukáš,et al. Bile acid malabsorption in inflammatory bowel disease: Assessment by serum markers , 2011, Inflammatory bowel diseases.
[37] A. Öst,et al. Low levels of bile acids increase bacterial uptake in colonic biopsies from patients with collagenous colitis in remission , 2011, Alimentary pharmacology & therapeutics.
[38] J. Söderholm,et al. Importance of disrupted intestinal barrier in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.
[39] S. Duncan,et al. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers , 2010, Gut.
[40] Kyle Steenland,et al. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. , 2009, American journal of epidemiology.
[41] T. Langmann,et al. Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease. , 2009, World journal of gastroenterology.
[42] J. Chiang. Hepatocyte nuclear factor 4α regulation of bile acid and drug metabolism , 2009, Expert opinion on drug metabolism & toxicology.
[43] J. Chiang. Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism. , 2009, Expert opinion on drug metabolism & toxicology.
[44] K. Nagashima,et al. Hepatocyte nuclear factor 4&agr; in the intestinal epithelial cells protects against inflammatory bowel disease , 2008, Inflammatory bowel diseases.
[45] John W. Froehlich,et al. Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.
[46] J. Söderholm,et al. Dihydroxy bile acids increase mucosal permeability and bacterial uptake in human colon biopsies , 2007, Scandinavian journal of gastroenterology.
[47] Robert C Buck,et al. Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[48] J. Satsangi,et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[49] Timothy J Wallington,et al. Degradation of fluorotelomer alcohols: a likely atmospheric source of perfluorinated carboxylic acids. , 2004, Environmental science & technology.
[50] J. Söderholm,et al. Epithelia under metabolic stress perceive commensal bacteria as a threat. , 2004, The American journal of pathology.
[51] Philippe Arnaud,et al. Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. , 2002, Biological & pharmaceutical bulletin.
[52] B. Strandvik,et al. Serum bile acids in relation to disease activity and intake of dietary fibers in juvenile ulcerative colitis. , 1991, Digestion.
[53] J. Lennard-jones,et al. Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.
[54] W. Roediger,et al. Colonic bicarbonate output as a test of disease activity in ulcerative colitis. , 1984, Journal of clinical pathology.
[55] R. I. Breuer,et al. Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis. , 1982, Gut.
[56] F. Kern,et al. Bile salt malabsorption in regional ileitis, ileal resection and mannitol-induced diarrhea. , 1968, The Journal of clinical investigation.